Cargando…

Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory

Coronavirus disease 2019 (COVID-19) surveillance, in Brazil, initiated shortly after its description, in China. Our aim was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and additional pathogens in samples from the initial phase of the outbreak in Brazil, from late February...

Descripción completa

Detalles Bibliográficos
Autores principales: Matos, Aline da Rocha, Motta, Fernando Couto, Caetano, Braulia Costa, Ogrzewalska, Maria, Garcia, Cristiana Couto, Lopes, Jonathan Christian Oliveira, Miranda, Milene, Livorati, Miriam Teresinha Furlam Prando, Abreu, André, Brown, David, Siqueira, Marilda Mendonça
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508282/
https://www.ncbi.nlm.nih.gov/pubmed/32965332
http://dx.doi.org/10.1590/0074-02760200232
_version_ 1783585395223560192
author Matos, Aline da Rocha
Motta, Fernando Couto
Caetano, Braulia Costa
Ogrzewalska, Maria
Garcia, Cristiana Couto
Lopes, Jonathan Christian Oliveira
Miranda, Milene
Livorati, Miriam Teresinha Furlam Prando
Abreu, André
Brown, David
Siqueira, Marilda Mendonça
author_facet Matos, Aline da Rocha
Motta, Fernando Couto
Caetano, Braulia Costa
Ogrzewalska, Maria
Garcia, Cristiana Couto
Lopes, Jonathan Christian Oliveira
Miranda, Milene
Livorati, Miriam Teresinha Furlam Prando
Abreu, André
Brown, David
Siqueira, Marilda Mendonça
author_sort Matos, Aline da Rocha
collection PubMed
description Coronavirus disease 2019 (COVID-19) surveillance, in Brazil, initiated shortly after its description, in China. Our aim was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and additional pathogens in samples from the initial phase of the outbreak in Brazil, from late February to late March. From 707 samples analysed, 29 (4.1%) were SARS-CoV-2 positive. Fever and cough were their most prevalent symptoms. Co-detection of rhinovirus was observed in 2 (6.9%) cases. Additional pathogens were identified in 66.1% of the SARS-CoV-2 negative cases, mainly rhinovirus and influenza A(H1N1)pdm09. Thus, we emphasise the importance of differential diagnosis in COVID-19 suspected cases.
format Online
Article
Text
id pubmed-7508282
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Instituto Oswaldo Cruz, Ministério da Saúde
record_format MEDLINE/PubMed
spelling pubmed-75082822020-09-28 Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory Matos, Aline da Rocha Motta, Fernando Couto Caetano, Braulia Costa Ogrzewalska, Maria Garcia, Cristiana Couto Lopes, Jonathan Christian Oliveira Miranda, Milene Livorati, Miriam Teresinha Furlam Prando Abreu, André Brown, David Siqueira, Marilda Mendonça Mem Inst Oswaldo Cruz Short Communication Coronavirus disease 2019 (COVID-19) surveillance, in Brazil, initiated shortly after its description, in China. Our aim was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and additional pathogens in samples from the initial phase of the outbreak in Brazil, from late February to late March. From 707 samples analysed, 29 (4.1%) were SARS-CoV-2 positive. Fever and cough were their most prevalent symptoms. Co-detection of rhinovirus was observed in 2 (6.9%) cases. Additional pathogens were identified in 66.1% of the SARS-CoV-2 negative cases, mainly rhinovirus and influenza A(H1N1)pdm09. Thus, we emphasise the importance of differential diagnosis in COVID-19 suspected cases. Instituto Oswaldo Cruz, Ministério da Saúde 2020-09-18 /pmc/articles/PMC7508282/ /pubmed/32965332 http://dx.doi.org/10.1590/0074-02760200232 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Short Communication
Matos, Aline da Rocha
Motta, Fernando Couto
Caetano, Braulia Costa
Ogrzewalska, Maria
Garcia, Cristiana Couto
Lopes, Jonathan Christian Oliveira
Miranda, Milene
Livorati, Miriam Teresinha Furlam Prando
Abreu, André
Brown, David
Siqueira, Marilda Mendonça
Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory
title Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory
title_full Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory
title_fullStr Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory
title_full_unstemmed Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory
title_short Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory
title_sort identification of sars-cov-2 and additional respiratory pathogens cases under the investigation of covid-19 initial phase in a brazilian reference laboratory
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508282/
https://www.ncbi.nlm.nih.gov/pubmed/32965332
http://dx.doi.org/10.1590/0074-02760200232
work_keys_str_mv AT matosalinedarocha identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT mottafernandocouto identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT caetanobrauliacosta identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT ogrzewalskamaria identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT garciacristianacouto identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT lopesjonathanchristianoliveira identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT mirandamilene identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT livoratimiriamteresinhafurlamprando identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT abreuandre identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT browndavid identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory
AT siqueiramarildamendonca identificationofsarscov2andadditionalrespiratorypathogenscasesundertheinvestigationofcovid19initialphaseinabrazilianreferencelaboratory